000 | 01908 a2200589 4500 | ||
---|---|---|---|
005 | 20250518084350.0 | ||
264 | 0 | _c20201103 | |
008 | 202011s 0 0 eng d | ||
022 | _a1476-5551 | ||
024 | 7 |
_a10.1038/s41375-020-0735-y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRambaldi, Alessandro | |
245 | 0 | 0 |
_aSafety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study. _h[electronic resource] |
260 |
_bLeukemia _c08 2020 |
||
300 |
_a2234-2237 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Letter; Multicenter Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aCarbamates _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aJanus Kinase 2 _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMaximum Tolerated Dose |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aPolycythemia Vera _xdrug therapy |
650 | 0 | 4 | _aQuality of Life |
700 | 1 | _aIurlo, Alessandra | |
700 | 1 | _aVannucchi, Alessandro M | |
700 | 1 | _aNoble, Richard | |
700 | 1 | _avon Bubnoff, Nikolas | |
700 | 1 | _aGuarini, Attilio | |
700 | 1 | _aMartino, Bruno | |
700 | 1 | _aPezzutto, Antonio | |
700 | 1 | _aCarli, Giuseppe | |
700 | 1 | _aDe Muro, Marianna | |
700 | 1 | _aLuciani, Stefania | |
700 | 1 | _aMcMullin, Mary Frances | |
700 | 1 | _aCambier, Nathalie | |
700 | 1 | _aMarolleau, Jean-Pierre | |
700 | 1 | _aMesa, Ruben A | |
700 | 1 | _aTibes, Raoul | |
700 | 1 | _aPancrazzi, Alessandro | |
700 | 1 | _aGesullo, Francesca | |
700 | 1 | _aBettica, Paolo | |
700 | 1 | _aManzoni, Sara | |
700 | 1 | _aDi Tollo, Silvia | |
773 | 0 |
_tLeukemia _gvol. 34 _gno. 8 _gp. 2234-2237 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41375-020-0735-y _zAvailable from publisher's website |
999 |
_c30623923 _d30623923 |